0000899243-22-021934.txt : 20220610 0000899243-22-021934.hdr.sgml : 20220610 20220610163943 ACCESSION NUMBER: 0000899243-22-021934 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220609 FILED AS OF DATE: 20220610 DATE AS OF CHANGE: 20220610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Armanino Andrew J. CENTRAL INDEX KEY: 0001807550 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39864 FILM NUMBER: 221009495 MAIL ADDRESS: STREET 1: C/O CALIFORNIA BANCORP STREET 2: 1300 CLAY STREET, FIFTH FLOOR CITY: OAKLAND STATE: CA ZIP: 94612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Better Therapeutics, Inc. CENTRAL INDEX KEY: 0001832415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1028 BUSINESS ADDRESS: STREET 1: 311 WEST 43RD STREET, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-493-6558 MAIL ADDRESS: STREET 1: 311 WEST 43RD STREET, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II DATE OF NAME CHANGE: 20201116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-09 0 0001832415 Better Therapeutics, Inc. BTTX 0001807550 Armanino Andrew J. C/O BETTER THERAPEUTICS, INC. 548 MARKET STREET, #49404 SAN FRANCISCO CA 94104 1 0 0 0 Common Stock 2022-06-09 4 P 0 25000 1.6542 A 151328 I By Armanino Trust Common Stock 13334 D Stock Option (Right to Buy) 1.66 2022-06-09 4 A 0 15000 0.00 A 2032-06-08 Common Stock 15000 15000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6475 to $1.6791, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust. The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 9, 2022. /s/ Mark Heinen, Attorney-in-Fact 2022-06-10